National HIV Testing Day has raised awareness and confront stereotypes about HIV. Learn about HIV testing options and ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.

The FDA approval marks the first approval of a type of pre-exposure prophylaxis that would only require 2 treatments per year ...

The Ministry of Health officially announced the introduction of the injectable medication Cabotegravir on June 27, a drug which is designed to deliver pre-exposure prevention of HIV infections. This ...

The US Food and Drug Administration (FDA) has approved a new shot to prevent HIV, offering a long-acting alternative to daily ...

The United States Food and Drug Administration, FDA, has approved a new long-acting injectable drug, Lenacapavir, for the ...

Discover how young healthcare innovators from Durban are transforming clinical trials and community health, earning accolades ...

As Congress finalizes a sweeping new federal spending bill, healthcare providers are sounding the alarm over what could be at ...

Although HIV may affect sperm quality and male fertility by numerous mechanisms the face of HIV care has dramatically changed ...

Lenacapavir belongs to a new class of antiretrovirals known as capsid inhibitors. In large-scale clinical trials conducted ...

The U.S. Food and Drug Administration (FDA) on June 18 approved a newly developed HIV/AIDS prevention drug that only needs to ...

FRIDAY, June 20, 2025 (HealthDay News) — A new shot to prevent HIV infection has just been approved — and it only needs to be ...